Position in ESPR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$0
New position
Shares Held
800,000
first reported quarter
Ownership
0.311%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Vestcor Inc holds $18,826,284 across 17 Drug Manufacturers - Specialty & Generic names. ESPR ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,447 | $7,285,988 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
10,439 | $1,759,389 | |
| 3 | ALKS |
Alkermes plc.
|
30,230 | $1,584,052 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
34,263 | $1,405,810 | |
| 5 | VTRS |
Viatris Inc
|
87,478 | $1,389,150 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
71,721 | $1,241,490 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
13,123 | $839,215 | |
| 8 | ZTS |
Zoetis Inc.
|
11,578 | $831,995 |
All Filings in ESPR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 800,000 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||